In our results, ZNF224 is negatively associated with cancer dedifferentiation—KIRC tumors that exhibit cancer stem cell-like phenotype express significantly lower levels of ZNF224, suggesting its tumor-suppressive role in kidney cancer. This evidence concerns the gene ZNF224 and kidney cancer.